Antigen Or Antibody Entrapped Within The Carrier (e.g., Gel, Hollow Fiber, Etc.) Patents (Class 436/535)
  • Patent number: 6686158
    Abstract: Disclosed are materials and methods for detecting biomolecules in samples employing transponders associated with the bead(s) used as the solid phase in the assay, and information pertinent to the assay is encoded on the transponders memory elements. A dedicated read/write device is used remotely to encode or remotely to read the information. The invention can be used in direct or competitive ELISA-type assays, or in multiplex assays for the simultaneous assay of several analytes.
    Type: Grant
    Filed: July 17, 2001
    Date of Patent: February 3, 2004
    Assignee: Pharma Seg, Inc.
    Inventor: Wlodek Mandecki
  • Patent number: 6680210
    Abstract: The present invention provides imprint compositions useful for capturing, isolating, detecting and/or quantifying macromolecules in a sample, methods of making and using the same. Generally, the imprint compositions comprise a matrix material defining an imprint of a template molecule, and the template molecule typically corresponds to a portion of a macromolecule of interest.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: January 20, 2004
    Assignee: Aspira Biosystems, Inc.
    Inventor: Chin-Shiou Huang
  • Patent number: 6680208
    Abstract: A method and device is disclosed for rapidly identifying a large number of proteins by placing a protein mixture in a sample chamber of an electrophoresis gel, and performing electrophoresis to separate the mixture by molecular weight, in a direction of separation, into a two-dimensional separation pattern in the gel. The separation pattern is transferred to a membrane, such as a sheet of nitrocellulose, and a plate with a set of separate, side-by-side slots is then applied to the membrane. A different antibody mixture is introduced into each of the slots by perfusing each antibody mixture under pressure through the slots. The antibody mixture that is perfused through each slot recognizes several different proteins of sufficiently different molecular weights that different protein bands can be resolved by the antibody mixture in each slot.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: January 20, 2004
    Assignee: Becton, Dickinson and Company
    Inventors: Roberto Campos-González, Steven Darrell Hume
  • Patent number: 6673561
    Abstract: Thrombotic or thromboembolic disease is detected or monitored by determining the presence or amount B in a urine sample.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: January 6, 2004
    Assignee: Regents of the University of California
    Inventor: Timothy A. Morris
  • Patent number: 6667159
    Abstract: A biosensor, sensor array, sensing method and sensing apparatus are provided in which individual cells or randomly mixed populations of cells, having unique response characteristics to chemical and biological materials, are deployed in a plurality of microwells formed at the distal end of individual fibers within a fiber optic array. The biosensor array utilizes an optically interrogatable encoding scheme for determining the identity and location of each cell type in the array and provides for simultaneous measurements of large numbers of individual cell responses to target analytes. The sensing method utilizes the unique ability of cell populations to respond to biologically significant compounds in a characteristic and detectable manner. The biosensor array and measurement method may be employed in the study of biologically active materials, in situ environmental monitoring, monitoring of a variety of bioprocesses, and for high throughput screening of large combinatorial chemical libraries.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: December 23, 2003
    Assignee: Trustees of Tufts College
    Inventors: David R. Walt, Laura Taylor
  • Patent number: 6649419
    Abstract: A method and apparatus for extracting, identifying, and manipulating proteins or peptides from a solution uses paramagnetic beads having a coating with an affinity for the target component. In one embodiment, paramagnetic beads coated with C18 are used to adsorb proteins and peptides. The beads can be used to purify, immobilize and assay antibodies. By cycling the beads, many times greater molar amount of binding partner may be separated from a solution. A magnetic probe is used to capture the beads and transfer the beads to selected processing stages.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: November 18, 2003
    Assignee: Large Scale Proteomics Corp.
    Inventor: N. Leigh Anderson
  • Patent number: 6630358
    Abstract: Protein arrays for the parallel, in vitro screening of biomolecular activity are provided. Methods of using the protein arrays are also disclosed. On the arrays, a plurality of different proteins, such as different members of a single protein family, are immobilized on one or more organic thinfilms on the substrate surface. The protein arrays are particularly useful in drug development, proteomics, and clinical diagnostics.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: October 7, 2003
    Assignee: Zyomyx, Incorporated
    Inventors: Peter Wagner, Dana Ault-Riche, Steffen Nock, Christian Itin
  • Patent number: 6620628
    Abstract: An assay element for analyzing a charged analyte employs an immobilized receptor and a material having a net charge which is the same as that of the analyte. In a preferred embodiment, the analyte is an aminoglycoside and the material is a polymer having a net positive charge.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: September 16, 2003
    Assignee: Ortho-Clinical Diagnostics, Inc.
    Inventors: Richard Sutton, Susan Danielson, Jerome Swartz, Linda Mauck
  • Patent number: 6613512
    Abstract: Electrokinetic devices having a computer for correcting for electrokinetic effects are provided. Methods of correcting for electrokinetic effects by establishing the velocity of reactants and products in a reaction in electrokinetic microfluidic devices are also provided. These microfluidic devices can have substrates with channels, depressions, and/or wells for moving, mixing and monitoring precise amounts of analyte fluids.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: September 2, 2003
    Assignee: Caliper Technologies Corp.
    Inventors: Anne R. Kopf-Sill, Andrea W. Chow, Claudia B. Jaffe, Steven A. Sunberg, John Wallace Parce
  • Patent number: 6579687
    Abstract: Methods and compositions are described for the detection and quantitation of cardiac specific troponin I and troponin T in samples. Cardiac-specific troponin isoforms exist in various forms in the blood, including free and complexed forms. By selecting antibodies that are sensitive and/or insensitive to these various forms, the present invention can provide immunoassays that more accurately reflect the clinical state of an individual. These described methods and compositions can be used for providing indicators of myocardial infarction and other cardiac pathologies.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: June 17, 2003
    Assignee: Biosite Incorporated
    Inventors: Kenneth F. Buechler, Paul H. McPherson
  • Patent number: 6558961
    Abstract: Methods for assessing immunocompetence, cellular or humoral immunity, antigen exposure, or allergic conditions in an individual by accelerating diagnostic particles into a target skin site in the individual are provided.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: May 6, 2003
    Assignee: PowderJect Research Limited
    Inventors: David F. Sarphie, Lee K. Roberts, Deborah L. Fuller
  • Patent number: 6555389
    Abstract: Devices and methods are provided using microfluidic devices for manipulating small volumes and determining a variety of chemical and physical events. The devices rely upon an opening to the atmosphere of a small volume in a zone, where a sample is placed in the zone where evaporation can occur. The zone is maintained in contact with a liquid medium that serves to replenish the liquid in the zone and maintain the composition of the mixture in the zone substantially constant. The diffusion of components in the zone is restricted during the course of the determination by the liquid flux into the zone.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: April 29, 2003
    Assignee: Aclara BioSciences, Inc.
    Inventors: Edwin F. Ullman, Sharat Singh, Ian Gibbons, Travis Boone, Torlief Bjornson
  • Publication number: 20030044777
    Abstract: Devices and methods for conducting binding reactions are described. The devices comprise first and second surfaces with channels extending between them. Specific binding reagents are immobilized in discrete groups of the channels. Sample passing through the channels reacts with the binding reagents. Binding of the sample component to the binding reagent in different groups of channels is detected providing information about sample composition. The devices provide increased surface area and accelerated reactions kinetics compared with flat surfaces.
    Type: Application
    Filed: December 17, 1998
    Publication date: March 6, 2003
    Inventor: KENNETH L. BEATTIE
  • Patent number: 6524790
    Abstract: Electrokinetic devices having a computer for correcting for electrokinetic effects are provided. Methods of correcting for electrokinetic effects by establishing the velocity of reactants and products in a reaction in electrokinetic microfluidic devices are also provided. These microfluidic devices can have substrates with channels, depressions, and/or wells for moving, mixing and monitoring precise amounts of analyte fluids.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: February 25, 2003
    Assignee: Caliper Technologies Corp.
    Inventors: Anne R. Kopf-Sill, Andrea W. Chow, Claudia B. Cohen, Steven A. Sundberg, John Wallace Parce
  • Publication number: 20030027241
    Abstract: Disclosed are methods and devices for detection of bacteria based on recognition and infection of one or more selected strains of bacteria with bacteriophage genetically modified to cause production of an inducer molecule in the bacterium following phage infection. The inducer molecule is released from the infected bacterium and is detected by genetically modified bacterial bioreporter cells designed to emit bioluminescence upon stimulation by the inducer. Autoamplification of the bioluminescent signal permits detection of low levels of bacteria without sample enrichment. Also disclosed are methods of detection for select bacteria, and kits for detection of select bacteria based on the described technology.
    Type: Application
    Filed: July 20, 2001
    Publication date: February 6, 2003
    Inventors: Gary S. Sayler, Steven A. Ripp, Bruce M. Applegate
  • Patent number: 6514771
    Abstract: A method and apparatus for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution. Light-controlled electrokinetic assembly of particles near surfaces relies on the combination of three functional elements: the AC electric field-induced assembly of planar aggregates; the patterning of the electrolyte/silicon oxide/silicon interface to exert spatial control over the assembly process; and the real-time control of the assembly process via external illumination. The present invention provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: February 4, 2003
    Assignee: Bioarray Solutions
    Inventor: Michael Seul
  • Patent number: 6514773
    Abstract: Subject matter of the invention is a method for detecting surface contamination by an analyte by wiping the analyte off the surface with the aid of a wiping surface, eluting the analyte from the wiping surface with an eluant, and detecting the analyte in the eluate in an immunological detection reaction, characterized in that: a) the surface to be tested for the analyte is wiped with a wiping surface, b) the wiping surface is brought into contact with the planar surface of a capillary active, chromatographic test strip which has an eluant application zone at its one end and a target zone at its other end whereby contact is made in an area between these two zones, c) eluting liquid is applied onto the zone provided for this purpose, said liquid moving toward the target zone passes the contact site with the wiping surface as a consequence of capillary forces, whereby analyte is taken up by the eluant, and d) in the target zone, the analyte is measured in an immunological binding reaction.
    Type: Grant
    Filed: July 24, 1995
    Date of Patent: February 4, 2003
    Assignee: Securetec Detektions-Systeme AG
    Inventors: Christian Klein, Hans-Peter Josel, Ada Goerlach-Graw, Reinhold Hilpert, Florian Binder, Josef Ritter, Rudolf Zimmermann
  • Patent number: 6498010
    Abstract: A solid state device for performing multi-analyte assays, comprises a substrate and a multiplicity of discrete reaction sites each bearing a ligand covalently bonded to the substrate, wherein the surface of the substrate between the reaction sites is inert with respect to analyte. Such a device may be obtained by a process of activating the surface of the substrate, and applying an array of ligands on to discrete areas on the surface.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: December 24, 2002
    Assignee: Randox Laboratories, LTD
    Inventors: Stephen Peter Fitzgerald, John Victor Lamont, Robert Ivan McConnell, El Ouard Benchikh
  • Patent number: 6492127
    Abstract: A lateral flow testing device is provided for testing a biological fluid for the presence of methamphetamines. The device includes a substrate element such as a nitrocellulose strip, including an antibody zone and an immobilized drug conjugate zone for detecting presence of methamphetamines, and an on-board chemical reactant for preventing undesirable cross-reactivity to ephedrine and/or pseudoephedrine that may be present in the biological fluid being tested. Preferably, the on-board chemical reactant is sodium periodate. Methods for preparing test devices are provided including the step of striping a substrate sheet with a solution containing sodium periodate during manufacture of methamphetamine lateral flow test strips.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: December 10, 2002
    Assignee: Varian, Inc.
    Inventors: Raegan E. Goodell, Dennis D. Blevins
  • Patent number: 6485987
    Abstract: The present invention relates to methods and compositions for the direct detection of analytes using color changes that occur in immobilized biopolymeric material in response to selective binding of analytes to their surface. In particular, the present invention provides methods and compositions related to the encapsulation of biopolymeric material into metal oxide glass using the sol-gel method.
    Type: Grant
    Filed: February 8, 2000
    Date of Patent: November 26, 2002
    Assignees: Regents of the University of California, Sandia Corporation
    Inventors: Deborah H. Charych, Darryl Sasaki, Stacey Yamanaka
  • Patent number: 6479302
    Abstract: The invention concerns a method for the immunological determination of an analyte in a sample using magnetic particles coated with the analyte to be determined or analyte-specific bonding partners and directly detectable non-magnetic particles coated with analyte-specific bonding partners or the analyte to be determined or using a non-magnetic substance which is indirectly detectable, and incubation of the reaction mixture. The method is characterized in that the magnetic particles are subsequently separated from the reaction mixture using a magnetic test strip and the analyte concentration is determined directly.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: November 12, 2002
    Assignee: Merck Patent Gesellschaft MIT
    Inventor: Bernd Dremel
  • Patent number: 6475805
    Abstract: A test device, system and method, the device composed of an elongated, toothbrush-shaped, transparent, plastic housing and a lateral-flow test strip for the detection of an analyte, such as a beta-lactam in milk, in the housing, the housing having an expansion cavity to receive expanded, liquid-contacted, absorbing material in the test strip, and to control lateral flow rate and times in the test strip.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: November 5, 2002
    Assignee: Charm Sciences, Inc.
    Inventors: Stanley E. Charm, Richard Skiffington, Robert J. Markovsky, Eliezer Zomer, Steven J. Saul
  • Patent number: 6475808
    Abstract: Protein arrays for the parallel, in vitro screening of biomolecular activity are provided. Methods of using the protein arrays are also disclosed. On the arrays, a plurality of different proteins, such as different members of a single protein family, are immobilized on one or more organic thinfilms on the substrate surface. The protein arrays are particularly useful in drug development, proteomics, and clinical diagnostics.
    Type: Grant
    Filed: July 14, 1999
    Date of Patent: November 5, 2002
    Assignee: Zyomyx, Incorporated
    Inventors: Peter Wagner, Dana Ault-Riche, Steffen Nock, Christian Itin
  • Patent number: 6468759
    Abstract: The present invention relates to methods and compositions for the direct detection of membrane conformational changes through the detection of color changes in biopolymeric materials. In particular, the present invention allows for the direct colorimetric detection of membrane modifying reactions and analytes responsible for such modifications and for the screening of reaction inhibitors.
    Type: Grant
    Filed: March 2, 1998
    Date of Patent: October 22, 2002
    Assignee: Regents of the University of California
    Inventor: Deborah Charych
  • Patent number: 6468811
    Abstract: A method and apparatus for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution. Light-controlled electrokinetic assembly of particles near surfaces relies on the combination of three functional elements: the AC electric field-induced assembly of planar aggregates; the patterning of the electrolyte/silicon oxide/silicon interface to exert spatial control over the assembly process; and the real-time control of the assembly process via external illumination. The present invention provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: October 22, 2002
    Assignee: Bioarray Solutions
    Inventor: Michael Seul
  • Patent number: 6458599
    Abstract: A method for making an imprint composition capable of capturing a macromolecule of interest, comprising the steps of (a) solidifying a fluidic matrix material capable of retaining shaped cavities when in a solid or semi-solid form in the presence of a template molecule that corresponds to a portion of the macromolecule, thereby yielding a solid or semi-solid matrix material having template molecules entrapped therein; and (b) removing the template molecules from the solid or semi-solid matrix material, yielding an imprint composition capable of capturing the macromolecule.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: October 1, 2002
    Assignee: Aspira Biosystems, Inc.
    Inventor: Chin-Shiou Huang
  • Publication number: 20020137233
    Abstract: The present invention provides the design, synthesis and characterization of compositions comprising asymmetric bolaamphiphilic lipids that form extended polymeric ribbons and wide sheets. These compositions may be doped, or interspersed, with various compounds to fine-tune the fluidity and rigidity of the bolaamphiphilic lipid composition, and promote other morphologies of the composition, including fluid vesicles and truncated flat sheets. Upon an increase in pH these compositions undergo a calorimetric and morphological transformation.
    Type: Application
    Filed: March 12, 2002
    Publication date: September 26, 2002
    Inventors: Raymond C. Stevens, Quan Cheng, Jie Song
  • Patent number: 6444261
    Abstract: A particle resistant to storage of at least one first and at least one second component, wherein said second component of at least one crosslinkable polymer as a shell at least partially envelops and/or encloses said first component as a core and said first component has at least one ascertainable property, obtainable by reacting said first component with the crosslinkable polymer and subsequently reacting the formed product with a crosslinking agent such that the first component with resistance to storage remains within the second component.
    Type: Grant
    Filed: July 20, 1998
    Date of Patent: September 3, 2002
    Assignee: Abion Beteiligungs-und Verwaltungsgesellschaft mbH
    Inventors: Dmitri Plaksine, Elena Gromakovskaia, Christoph Erhardt
  • Patent number: 6436649
    Abstract: The invention discloses a method for detecting and/or quantifying a hapten in a homogeneous phase, comprising the following steps: adding a known quantity of a hapten inhibitor complex to the solution containing the hapten to be detected and/or quantified; adding to the solution a quantity of antibodies corresponding to the quantity of the hapten/inhibitor complex; adding to the solution a type C &bgr;-lactamase having an active site for two substrates in antigenic competition in the said active site, the first substrate being a reporter substrate capable of being transformed into a detectable and/or quantifiable product, preferably by visible UV radiation measurement, the second substrate being the hapten/inhibitor complex acting on the hydrolysis rate of the reporter substrate; detecting and/or quantifying the concentration of the product resulting from the transformation of the reporter substrate, the Km constant of the reporter substrate being at least a hundred times higher than the Km constant of the ha
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: August 20, 2002
    Assignee: Le Region Wallone
    Inventors: Michel Kohl, Roger Renotte, Gianangelo Ghitti, Guy Sarlet, Robert Lejeune
  • Patent number: 6432719
    Abstract: The present invention provides a system and process providing variable access to, as well as quick and accurate dispensing of, numerous selected reagents from a mass storage arrangement. According to one embodiment, an array of reagent dispensers is supported over a movable platform assembly. The platform assembly aligns a designated receiving receptacle under a selected dispenser of the array so that a respective reagent can be dispensed therein. Advantageously, the apparatus and process can be carried out under the control of a programmed computer.
    Type: Grant
    Filed: February 16, 1999
    Date of Patent: August 13, 2002
    Assignee: PE Corporation (NY)
    Inventors: Charles S. Vann, David M. Cox
  • Patent number: 6420183
    Abstract: In a process for the quantitative optical analysis of fluorescently labelled biological cells 5, a cell layer on a transparent support at the bottom 2 of a reaction vessel 1 is in contact with a solution 3 containing the fluorescent dye 4. The sensitivity of analytical detection can be considerably improved if to the fluorescent dye 4 already present in addition a masking dye 9, which absorbs the excitation light 6 for the fluorescent dye 4 and/or its emission light 7, is added to the solution 3 and/or if a separating layer 10 permeable to the solution and absorbing and/or reflecting the excitation light 6 or the emission light 7 is applied to the cell layer at the bottom 2. The separating layer 10 must be composed such that it has a high power of reflection for the luminescent light 11.
    Type: Grant
    Filed: November 20, 1998
    Date of Patent: July 16, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thoams Krahn, Wolfgang Paffhausen, Andreas Schade, Martin Bechem, Delf Schmidt
  • Patent number: 6406921
    Abstract: Protein arrays and protein-coated substrates for the parallel, in vitro screening of biomolecular activity are provided. Methods of using the protein-coated substrates and protein arrays are also disclosed. A plurality of different members of a single protein family may be immobilized on the protein-coated substrate or array. The protein-coated substrates and protein arrays are particularly useful in high-throughput drug screening and clinical diagnostics.
    Type: Grant
    Filed: July 14, 1998
    Date of Patent: June 18, 2002
    Assignee: Zyomyx, Incorporated
    Inventors: Peter Wagner, Dana Ault-Riche, Steffen Nock, Christian Itin
  • Publication number: 20020072129
    Abstract: A container having a flexible wall receives a continuous flow of a biological fluid that includes a target antigen and emits a continuous flow of the biological fluid at least partially depleted from the target antigen. The container further comprises a compartment with magnetic beads coupled to an affinity marker that binds the target antigen, and the target antigen is separated from the biological fluid using a magnetic force and an automatic mechanical force, wherein at least one of the magnetic force and automatic mechanical force is transmitted through the flexible wall.
    Type: Application
    Filed: October 11, 2001
    Publication date: June 13, 2002
    Inventors: Michael Poirier, Vijay K. Mahant
  • Publication number: 20020071908
    Abstract: A particle resistant to storage of at least one first and at least one second component, wherein
    Type: Application
    Filed: July 20, 1998
    Publication date: June 13, 2002
    Inventors: DMITRI PLAKSINE, ELENA GROMAKOVSKAIA, CHRISTOPH ERHARDT
  • Patent number: 6379908
    Abstract: The present invention relates to bioassay materials useful for the detection of toxic substances and, more particularly, to packaging materials for food and other products, along with methods for their manufacture and use. The invention provides a unique composite material capable of detecting and identifying multiple biological materials within a single package. The biological material identification system is designed for incorporation into existing types of flexible packaging material such as polyvinylchloride or polyolefin films, and its introduction into the existing packaging infrastructure will require little or no change to present systems or procedures.
    Type: Grant
    Filed: April 17, 2000
    Date of Patent: April 30, 2002
    Assignee: Toxin Alert, Inc.
    Inventor: William T. Bodenhamer
  • Patent number: 6376187
    Abstract: Disclosed are materials and methods for detecting biomolecules in samples employing transponders associated with the bead(s) used as the solid phase in the assay, and information pertinent to the assay is encoded on the transponders memory elements. A dedicated read/write device is used remotely to encode or remotely to read the information. The invention can be used in direct or competitive ELISA-type assays, or in multiplex assays for the simultaneous assay of several analytes.
    Type: Grant
    Filed: July 11, 2000
    Date of Patent: April 23, 2002
    Assignee: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Patent number: 6376204
    Abstract: The present invention relates to bioassay materials useful for the detection of toxic substances and, more particularly, to packaging materials for food and other products, along with methods for their manufacture and use. The invention provides a unique composite material capable of detecting and identifying multiple biological materials within a single package. The biological material identification system is designed for incorporation into existing types of flexible packaging material such as polyvinylchloride or polyolefin films, and its introduction into the existing packaging infrastructure will require little or no change to present systems or procedures.
    Type: Grant
    Filed: April 17, 2000
    Date of Patent: April 23, 2002
    Assignee: Toxin Alert, Inc.
    Inventor: William T. Bodenhamer
  • Patent number: 6372517
    Abstract: Magnetic particles for separating biological mixtures consist of nacreous luster pigments with magnetic properties coated with a biological polymer.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: April 16, 2002
    Assignee: Innova-Gesellschaft zur Entwicklung und Vermarktung innovativer Produkte m.b.H.
    Inventor: Hans Lange
  • Patent number: 6365418
    Abstract: Arrays of protein-capture agents useful for the simultaneous detection of a plurality of proteins which are the expression products, or fragments thereof, of a cell or population of cells in an organism are provided. A variety of antibody arrays, in particular, are described. Methods of both making and using the arrays of protein-capture agents are also disclosed. The invention arrays are particularly useful for various proteomics applications including assessing patterns of protein expression and modification in cells.
    Type: Grant
    Filed: May 18, 2000
    Date of Patent: April 2, 2002
    Assignee: Zyomyx, Incorporated
    Inventors: Peter Wagner, Steffen Nock, Dana Ault-Riche, Christian Itin
  • Patent number: 6362011
    Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.
    Type: Grant
    Filed: February 2, 1999
    Date of Patent: March 26, 2002
    Assignee: Meso Scale Technologies, LLC
    Inventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland
  • Patent number: 6346376
    Abstract: This document describes an optical sensor unit and a procedure for the specific detection and identification of biomolecules at high sensitivity in real fluids and tissue homogenates. High detection limits are reached by the combination of i) label-free integrated optical detection of molecular interactions, ii) the use of specific bioconstituents for sensitive detection and iii) planar optical transducer surfaces appropriately engineered for suppression of non-specific binding, internal referencing and calibration. Applications include the detection of prion proteins and identification of those biomolecules which non-covalently interact with surface immobilized prion proteins and are intrinsically involved in the cause of prion related disease.
    Type: Grant
    Filed: May 11, 1999
    Date of Patent: February 12, 2002
    Assignee: Centre Suisse d'Electronique et de Mictotechnique SA
    Inventors: Hans Sigrist, Hui Gao, Rino E. Kunz, Jürg Dübendorfer, Carsten Korth, Markus Moser, Bruno Oesch
  • Patent number: 6323042
    Abstract: A displacement-type flow immunoassay is performed using a microcapillary passage. The inner wall of the microcapillary passage has immobilized thereon antibodies to the antigen of interest. Labeled antigen is immunologically bound to the immobilized antibodies. Sample antigen passing through the column displaces the labeled antigen. Downstream, the displaced labeled antigen is detected. The microcapillary format of the present invention enhances the sensitivity of the immunoassay over the sensitivity of displacement-type flow immunoassays performed in a column at similar flow rates.
    Type: Grant
    Filed: November 8, 1999
    Date of Patent: November 27, 2001
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Upvan Narang, Paul R. Gauger, Frances S. Ligler
  • Patent number: 6319676
    Abstract: The invention provides an improved test cell for detecting the presence of an analyte in a liquid sample. The device has an elongate casing defining a liquid sample inlet, a reservoir volume, a test volume, and a window through the casing at the test volume. Disposed within the cell is a sample absorbent, a novel biphasic substrate and a reservoir, together capable of transporting an aqueous solution within the casing along a flow path extending from the sample inlet through the test volume and into the reservoir volume. The invention further comprises a method for detecting the presence of an analyte in a liquid sample using the device and a biphasic chromatographic material for carrying out the method.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: November 20, 2001
    Assignee: Carter Wallace, Inc.
    Inventors: Albert Nazareth, Mary Beth Boyle, Yea-Shun Cheng
  • Patent number: 6312942
    Abstract: Substances such as chemical substances and biological substances including animal, vegetable and microbial cells are encapsulated using a process and an apparatus wherein a coil through which alternating current flows causes a magnet to vibrate creating vibrations such as in the range of between 300 to 4000 Hz that are transmitted to an encapsulating fluid containing the substance to form small substantially spherical particles containing the substance. The apparatus includes a pulsation chamber containing a movable wall for receiving the encapsulating fluid containing the substance to be encapsulated. A nozzle is spaced downstream from the pulsation chamber for receiving the encapsulating fluid from the pulsation chamber. A permanent magnet is mounted on the movable wall, and a coil is spaced from the permanent magnet by an air gap and is located proximate to the permanent magnet.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: November 6, 2001
    Assignee: Inotech AG
    Inventors: Raphael Plüss-Wenzinger, Fritz Widmer, Christoph Heinzen, Harry Brandenberger
  • Patent number: 6306665
    Abstract: Microporous solid phase materials that are suitable for lateral flow and other assays for detecting the presence of analytes in test samples, that are stable under variations in humidity and, even after storage for extended periods of time, can form stable covalent bonds with molecules containing a free primary or secondary amine group or sulfhydryl group are described. The invention further concerns chemically derivatized solid phase materials, and conjugates comprising such materials. Examples of lateral flow devices for the quantitative or semi-quantitative determination of an analyte in a biological sample are described.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: October 23, 2001
    Assignee: A-Fem Medical Corporation
    Inventors: Robert Lee Buck, Huiying Wang, Timothy Patrick Hyatt, Paul Andrew Mueggler
  • Patent number: 6297062
    Abstract: The present invention concerns a method for separating at least one species of biological entities from a sample solution, by contacting the sample with a matrix of magnetic particles formed on a substrate such as a sheet a gel, etc. The particles in the matrix are coupled to entities capable of specifically binding to the species of biological entities to be separated. The separation is carried out either for detection purposes for obtaining separately each species of biological entities or for synthesis purposes. The invention further concerns matrices of magnetic particles formed on various substrates and kits for use in the method.
    Type: Grant
    Filed: March 4, 1998
    Date of Patent: October 2, 2001
    Assignee: Bio-Magnetics Ltd.
    Inventor: Moshe Gombinski
  • Patent number: 6297020
    Abstract: Disclosed is an improvement to a dry assay device for determining the concentration of a first analyte in a sample of body fluid and a second analyte in the same sample of body fluid. The device involves the use of a strip of an absorbent material through which the sample of body fluid flows and wherein the first analyte is determined calorimetrically in a first region of the strip and the second analyte is determined by an immunoassay which takes place in a second region of the strip located downstream from the first region. The improvement involves placing the strip in a hollow casing having a top and a bottom and which is so constructed that when the top and bottom of the casing are mated there is formed a U shaped, body fluid impervious barrier around the first region of the strip to prevent the sample of body fluid from flowing in any direction other than in the direction of the second region of the strip.
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: October 2, 2001
    Assignee: Bayer Corporation
    Inventor: David A. Brock
  • Patent number: 6291249
    Abstract: A cell containing sample is separated into a cell containing portion and a substantially cell depleted portion, by mixing the sample with particles to produce a cell containing network, and separating the network from the remaining substantially cell depleted portion within a plurality of confining walls, wherein at least one of the walls is flexible. While in some aspects the separation is performed employing a magnetic force, in other aspects the separation is performed using two forces, wherein one force is a magnetic force and the other force is a mechanical force. It is contemplated that whole blood may be used as the sample, and that the cell-containing portion largely comprises a network of inter-linked red blood cells. It is especially contemplated that separation involves antiligands, preferably primary antibodies that bind to a ligand such as antigen on or in red blood cell membranes, and secondary antibodies that bind to the primary antibodies.
    Type: Grant
    Filed: February 28, 2000
    Date of Patent: September 18, 2001
    Assignee: Qualigen, Inc.
    Inventors: Vijay Mahant, Byron Doneen
  • Patent number: 6287558
    Abstract: A device that includes a living cell or tissue and an agent that inhibits the ability of a host molecule to damage the cell or tissue. The device can be constructed in various forms including an implantable device, a composite microreactor and a double composite microreactor. The composite microreactor includes an internal particle that includes a living cell or tissue, an internal particle matrix that includes the living cell or tissue and an internal semipermeable coating enclosing the internal particle matrix, a gel super matrix in which the internal particle is embedded, and an agent that inhibits the ability of a host molecule to damage the cell or tissue. The double composite microreactor includes an internal particle, a particle that includes a particle matrix in which the internal particle is embedded, a super matrix in which the particle is embedded, and an agent that inhibits the ability of a host molecule to damage the living cell or tissue.
    Type: Grant
    Filed: August 1, 1997
    Date of Patent: September 11, 2001
    Assignee: BioHybrio Technologies LLC
    Inventors: Robert P. Lanza, Dawn M. Ecker, John Ringeling, Joanne P. Marsh, William Chick
  • Patent number: 6284459
    Abstract: Combinations, called matrices with memories, of matrix materials that are encoded with an optically readable code are provided. The matrix materials are those that are used in as supports in solid phase chemical and biochemical syntheses, immunoassays and hybridization reactions. The matrix materials may additionally include fluophors or other luminescent moieties to produce luminescing matrices with memories. The memories include electronic and optical storage media and also include optical memories, such as bar codes and other machine-readable codes. By virtue of this combination, molecules and biological particles, such as phage and viral particles and cells, that are in proximity or in physical contact with the matrix combination can be labeled by programming the memory with identifying information and can be identified by retrieving the stored information. Combinations of matrix materials, memories, and linked molecules and biological materials are also provided.
    Type: Grant
    Filed: September 5, 1996
    Date of Patent: September 4, 2001
    Assignee: Discovery Partners International
    Inventors: Michael P. Nova, Andrew E. Senyei, Xiao-Yi Xiao, Chanfeng Zhao, Hanan Potash